RLAY - Relay Therapeutics, Inc.

QQQ $ 441.71 $ 1.04 (0.24 %)

DIA $ 395.04 $ 1.18 (0.3 %)

SPY $ 520.76 $ 0.67 (0.13 %)

TLT $ 90.14 $ -0.51 (-0.56 %)

GLD $ 218.73 $ 1.76 (0.81 %)

Previous Close

$ 6.42

Open

$ 6.78

Bid

$ 6.40 x 300

Ask

$ 6.42 x 400

Day's Range

$ 6.23 - $ 6.81

52 Week Range

$ 5.70 - $ 13.32

Volume

1,407,410

Average Volume

Market Cap

840.01M

Beta (5Y Monthly)

$ 1.94

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-02-2024	03-31-2024	10-Q
2	02-22-2024	12-31-2023	10-K
3	11-02-2023	09-30-2023	10-Q
4	08-08-2023	06-30-2023	10-Q
5	05-04-2023	03-31-2023	10-Q
6	02-23-2023	12-31-2022	10-K
7	11-03-2022	09-30-2022	10-Q
8	08-04-2022	06-30-2022	10-Q
9	05-05-2022	03-31-2022	10-Q
10	02-24-2022	12-31-2021	10-K
11	11-10-2021	09-30-2021	10-Q
12	08-12-2021	06-30-2021	10-Q
13	05-13-2021	03-31-2021	10-Q
14	03-25-2021	12-31-2020	10-K
15	11-12-2020	09-30-2020	10-Q
16	08-27-2020	06-30-2020	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Key Takeaways From Relay Therapeutics Anal...
05/10/2024 18:00:35

Barclays Upgrades Relay Therapeutics to Ov...
05/10/2024 13:22:39

Barclays analyst Peter Lawson upgrades Relay Therapeutics (NASDAQ:RLAY) from Equal-Weight to Overweight and maintains the pr...

JMP Securities Reiterates Market Outperfor...
05/06/2024 15:07:14

JMP Securities analyst Silvan Tuerkcan reiterates Relay Therapeutics (NASDAQ:RLAY) with a Market Outperform and maintains $2...

Oppenheimer Reiterates Outperform on Relay...
05/06/2024 11:58:36

Oppenheimer analyst Matthew Biegler reiterates Relay Therapeutics (NASDAQ:RLAY) with a Outperform and lowers the price targe...

Relay Therapeutics Q1 2024 GAAP EPS $(0.62...
05/02/2024 21:52:54

Relay Therapeutics (NASDAQ:RLAY) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(...

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
04/10/2024 20:31:09

Relay Therapeutics: Q4 Earnings Insights
02/22/2024 21:25:16

Relay Therapeutics Q4 2023 GAAP EPS $(0.67...
02/22/2024 21:24:19

Relay Therapeutics (NASDAQ:RLAY) reported quarterly losses of $(0.67) per share which beat the analyst consensus estimate of $(...

Earnings Scheduled For February 22, 2024
02/22/2024 10:27:06

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

Relay Therapeutics's Earnings: A Preview
02/21/2024 18:01:47

Relay Therapeutics- Files Prospectus Of Pr...
01/10/2024 14:35:29

-SEC Filing

Relay Therapeutics Has Announced Private P...
01/08/2024 12:06:18

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
12/13/2023 13:07:30

HC Wainwright & Co. Maintains Buy Rating f...
12/11/2023 17:00:25

HC Wainwright & Co. Maintains Buy on Relay...
12/11/2023 11:26:37

HC Wainwright & Co. analyst Robert Burns maintains Relay Therapeutics (NASDAQ:RLAY) with a Buy and lowers the price targ...

HC Wainwright & Co. Maintains Buy on Relay...
11/08/2023 16:02:43

HC Wainwright & Co. analyst Robert Burns maintains Relay Therapeutics (NASDAQ:RLAY) with a Buy and lowers the price targ...

Relay Therapeutics Q3 EPS $(0.54) Beats $(...
11/02/2023 20:35:55

Relay Therapeutics (NASDAQ:RLAY) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(...

Earnings Scheduled For November 2, 2023
11/02/2023 08:56:34

Companies Reporting Before The Bell • AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on...

Relay Therapeutics's Earnings Outlook
11/01/2023 17:02:07

HC Wainwright & Co. Maintains Buy on Relay...
10/17/2023 17:25:08

HC Wainwright & Co. analyst Robert Burns maintains Relay Therapeutics (NASDAQ:RLAY) with a Buy and raises the price targ...